Warburg’s Ruoxi Chen: Innovative therapies will drive demand for Simtra BioPharma Solutions
Warburg Pincus and Advent International earlier this week completed the carve-out of Baxter International’s BPS business for $4.25bn.
Warburg Pincus and Advent International earlier this week completed the carve-out of Baxter International’s BPS business for $4.25bn.
Copyright PEI Media
Not for publication, email or dissemination